التفاصيل البيبلوغرافية
العنوان: |
A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma |
المؤلفون: |
Wei Zhou, Lee D. Cranmer, Igor Puzanov, Caroline Robert, Paolo A. Ascierto, Christian U. Blank, Antoni Ribas, April K.S. Salama, Omid Hamid, Steven J. O'Day, Adil Daud, F. Stephen Hodi, Rene Gonzalez, Jacob Schachter, Reinhard Dummer, Peter Soonmo Kang, Dirk Schadendorf, Joy Lis, Nicole Li, Anna C. Pavlick, Scot Ebbinghaus |
المصدر: |
Journal of Translational Medicine |
بيانات النشر: |
Springer Nature |
مصطلحات موضوعية: |
Medicine(all), Chemotherapy, medicine.medical_specialty, Temozolomide, business.industry, Biochemistry, Genetics and Molecular Biology(all), medicine.medical_treatment, Melanoma, Ipilimumab, General Medicine, Pembrolizumab, medicine.disease, Bioinformatics, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, Refractory, Internal medicine, medicine, Oral Presentation, Therapy duration, In patient, business, medicine.drug |
الوصف: |
2 and 10 mg/kg Q3W, respectively, over control (P |
اللغة: |
English |
تدمد: |
1479-5876 |
DOI: |
10.1186/1479-5876-13-s1-o5 |
الوصول الحر: |
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b244a2465aeff5cd7d5e9ef6b7ed366cTest |
حقوق: |
OPEN |
رقم الانضمام: |
edsair.doi.dedup.....b244a2465aeff5cd7d5e9ef6b7ed366c |
قاعدة البيانات: |
OpenAIRE |